Screener
Eikon Therapeutics, Inc. EIKN PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Eikon Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Eikon Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216791
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 16,919 | 12,542 |
| Restricted cash | 400 | 400 |
| Total current assets | 529,501 | 348,917 |
| Property and equipment, net | 138,067 | 142,898 |
| Operating lease right-of-use assets, net | 91,066 | 90,965 |
| Marketable securities, non-current | 83,828 | — |
| Restricted cash, non-current | 7,808 | 7,771 |
| Other non-current assets | 556 | 4,183 |
Item 1. Condensed Financial Statements (Unaudited).
FAQ
- What is Eikon Therapeutics, Inc.'s PP&E (net)?
- Eikon Therapeutics, Inc. (EIKN) reported PP&E (net) of $138.07M in Q1 2026.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Eikon Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude